Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Name Changes for Fungi of Medical Importance, 2016-2017.

Warnock DW.

J Clin Microbiol. 2019 Jan 30;57(2). pii: e01183-18. doi: 10.1128/JCM.01183-18. Print 2019 Feb. Review.

PMID:
30257904
2.

Name Changes for Fungi of Medical Importance, 2012 to 2015.

Warnock DW.

J Clin Microbiol. 2016 Dec 28;55(1):53-59. doi: 10.1128/JCM.00829-16. Print 2017 Jan. Review.

3.

Evolving strategies in the management of aspergillosis.

Magill SS, Chiller TM, Warnock DW.

Expert Opin Pharmacother. 2008 Feb;9(2):193-209. doi: 10.1517/14656566.9.2.193 . Review.

PMID:
18201144
4.

Coccidioides species as potential agents of bioterrorism.

Warnock DW.

Future Microbiol. 2007 Jun;2(3):277-83. Review.

PMID:
17661702
5.

Trends in the epidemiology of invasive fungal infections.

Warnock DW.

Nihon Ishinkin Gakkai Zasshi. 2007;48(1):1-12. Review.

6.

Fungal diseases: an evolving public health challenge.

Warnock DW.

Med Mycol. 2006 Dec;44(8):697-705. Review.

PMID:
17127626
7.

Comparison of multilocus sequence typing and Ca3 fingerprinting for molecular subtyping epidemiologically-related clinical isolates of Candida albicans.

Chowdhary A, Lee-Yang W, Lasker BA, Brandt ME, Warnock DW, Arthington-Skaggs BA.

Med Mycol. 2006 Aug;44(5):405-17.

PMID:
16882607
8.

Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome.

Park BJ, Arthington-Skaggs BA, Hajjeh RA, Iqbal N, Ciblak MA, Lee-Yang W, Hairston MD, Phelan M, Plikaytis BD, Sofair AN, Harrison LH, Fridkin SK, Warnock DW.

Antimicrob Agents Chemother. 2006 Apr;50(4):1287-92.

9.

Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.

Pfaller MA, Diekema DJ, Rex JH, Espinel-Ingroff A, Johnson EM, Andes D, Chaturvedi V, Ghannoum MA, Odds FC, Rinaldi MG, Sheehan DJ, Troke P, Walsh TJ, Warnock DW.

J Clin Microbiol. 2006 Mar;44(3):819-26.

10.

Candidemia in neonatal intensive care units: Barcelona, Spain.

Rodriguez D, Almirante B, Park BJ, Cuenca-Estrella M, Planes AM, Sanchez F, Gene A, Xercavins M, Fontanals D, Rodriguez-Tudela JL, Warnock DW, Pahissa A; Barcelona Candidemia Project Study Group.

Pediatr Infect Dis J. 2006 Mar;25(3):224-9.

PMID:
16511384
11.

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program.

Morgan J, Wannemuehler KA, Marr KA, Hadley S, Kontoyiannis DP, Walsh TJ, Fridkin SK, Pappas PG, Warnock DW.

Med Mycol. 2005 May;43 Suppl 1:S49-58.

PMID:
16110792
13.

An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001.

Park BJ, Sigel K, Vaz V, Komatsu K, McRill C, Phelan M, Colman T, Comrie AC, Warnock DW, Galgiani JN, Hajjeh RA.

J Infect Dis. 2005 Jun 1;191(11):1981-7. Epub 2005 Apr 20.

PMID:
15871133
14.

Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.

Almirante B, Rodríguez D, Park BJ, Cuenca-Estrella M, Planes AM, Almela M, Mensa J, Sanchez F, Ayats J, Gimenez M, Saballs P, Fridkin SK, Morgan J, Rodriguez-Tudela JL, Warnock DW, Pahissa A; Barcelona Candidemia Project Study Group.

J Clin Microbiol. 2005 Apr;43(4):1829-35.

15.

Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.

Borst A, Raimer MT, Warnock DW, Morrison CJ, Arthington-Skaggs BA.

Antimicrob Agents Chemother. 2005 Feb;49(2):783-7.

16.

In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003.

Cuenca-Estrella M, Rodriguez D, Almirante B, Morgan J, Planes AM, Almela M, Mensa J, Sanchez F, Ayats J, Gimenez M, Salvado M, Warnock DW, Pahissa A, Rodriguez-Tudela JL; Barcelona Candidemia Project Study Group.

J Antimicrob Chemother. 2005 Feb;55(2):194-9. Epub 2004 Dec 23.

PMID:
15618284
17.

A large histoplasmosis outbreak among high school students in Indiana, 2001.

Chamany S, Mirza SA, Fleming JW, Howell JF, Lenhart SW, Mortimer VD, Phelan MA, Lindsley MD, Iqbal NJ, Wheat LJ, Brandt ME, Warnock DW, Hajjeh RA.

Pediatr Infect Dis J. 2004 Oct;23(10):909-14.

PMID:
15602189
18.

Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.

Odds FC, Motyl M, Andrade R, Bille J, Cantón E, Cuenca-Estrella M, Davidson A, Durussel C, Ellis D, Foraker E, Fothergill AW, Ghannoum MA, Giacobbe RA, Gobernado M, Handke R, Laverdière M, Lee-Yang W, Merz WG, Ostrosky-Zeichner L, Pemán J, Perea S, Perfect JR, Pfaller MA, Proia L, Rex JH, Rinaldi MG, Rodriguez-Tudela JL, Schell WA, Shields C, Sutton DA, Verweij PE, Warnock DW.

J Clin Microbiol. 2004 Aug;42(8):3475-82.

19.

Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes.

Ghannoum MA, Chaturvedi V, Espinel-Ingroff A, Pfaller MA, Rinaldi MG, Lee-Yang W, Warnock DW.

J Clin Microbiol. 2004 Jul;42(7):2977-9.

20.

Candida parapsilosis characterization in an outbreak setting.

Kuhn DM, Mikherjee PK, Clark TA, Pujol C, Chandra J, Hajjeh RA, Warnock DW, Soil DR, Ghannoum MA.

Emerg Infect Dis. 2004 Jun;10(6):1074-81.

21.

Coccidioidomycosis among workers at an archeological site, northeastern Utah.

Petersen LR, Marshall SL, Barton-Dickson C, Hajjeh RA, Lindsley MD, Warnock DW, Panackal AA, Shaffer JB, Haddad MB, Fisher FS, Dennis DT, Morgan J.

Emerg Infect Dis. 2004 Apr;10(4):637-42.

23.

Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998-1999.

Lyon GM, Bravo AV, Espino A, Lindsley MD, Gutierrez RE, Rodriguez I, Corella A, Carrillo F, McNeil MM, Warnock DW, Hajjeh RA.

Am J Trop Med Hyg. 2004 Apr;70(4):438-42.

PMID:
15100461
24.

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.

Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, Phelan M, Morgan J, Lee-Yang W, Ciblak MA, Benjamin LE, Sanza LT, Huie S, Yeo SF, Brandt ME, Warnock DW.

J Clin Microbiol. 2004 Apr;42(4):1519-27.

25.

Resolution of discrepant results for Candida species identification by using DNA probes.

Coignard C, Hurst SF, Benjamin LE, Brandt ME, Warnock DW, Morrison CJ.

J Clin Microbiol. 2004 Feb;42(2):858-61.

26.

A large outbreak of histoplasmosis among American travelers associated with a hotel in Acapulco, Mexico, spring 2001.

Morgan J, Cano MV, Feikin DR, Phelan M, Monroy OV, Morales PK, Carpenter J, Weltman A, Spitzer PG, Liu HH, Mirza SA, Bronstein DE, Morgan DJ, Kirkman LA, Brandt ME, Iqbal N, Lindsley MD, Warnock DW, Hajjeh RA; Acapulco Histoplasmosis Working Group.

Am J Trop Med Hyg. 2003 Dec;69(6):663-9.

PMID:
14740886
27.

Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi.

Brandt ME, Warnock DW.

J Chemother. 2003 Nov;15 Suppl 2:36-47. Review.

PMID:
14708965
28.

Drug resistance genes and trailing growth in Candida albicans isolates.

Lee MK, Williams LE, Warnock DW, Arthington-Skaggs BA.

J Antimicrob Chemother. 2004 Feb;53(2):217-24. Epub 2003 Dec 19.

PMID:
14688046
29.

Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility.

Makarova NU, Pokrowsky VV, Kravchenko AV, Serebrovskaya LV, James MJ, McNeil MM, Lasker BA, Warnock DW, Reiss E.

J Clin Microbiol. 2003 May;41(5):1833-7.

30.

Outbreak of invasive aspergillosis among renal transplant recipients.

Panackal AA, Dahlman A, Keil KT, Peterson CL, Mascola L, Mirza S, Phelan M, Lasker BA, Brandt ME, Carpenter J, Bell M, Warnock DW, Hajjeh RA, Morgan J.

Transplantation. 2003 Apr 15;75(7):1050-3.

PMID:
12698098
31.

Stability of allelic frequencies and distributions of Candida albicans microsatellite loci from U.S. population-based surveillance isolates.

Lott TJ, Fundyga RE, Brandt ME, Harrison LH, Sofair AN, Hajjeh RA, Warnock DW.

J Clin Microbiol. 2003 Mar;41(3):1316-21.

32.

Population-based surveillance and a case-control study of risk factors for endemic lymphocutaneous sporotrichosis in Peru.

Lyon GM, Zurita S, Casquero J, Holgado W, Guevara J, Brandt ME, Douglas S, Shutt K, Warnock DW, Hajjeh RA; Sporotrichosis in Peru Investigation Team.

Clin Infect Dis. 2003 Jan 1;36(1):34-9. Epub 2002 Dec 12.

PMID:
12491199
33.

Fungal infections among returning travelers.

Panackal AA, Hajjeh RA, Cetron MS, Warnock DW.

Clin Infect Dis. 2002 Nov 1;35(9):1088-95. Epub 2002 Oct 11.

PMID:
12384843
34.

Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of candida species.

Cuenca-Estrella M, Lee-Yang W, Ciblak MA, Arthington-Skaggs BA, Mellado E, Warnock DW, Rodriguez-Tudela JL.

Antimicrob Agents Chemother. 2002 Nov;46(11):3644-7.

35.

Coccidioidomycosis in India: report of a second imported case.

Verghese S, Arjundas D, Krishnakumar KC, Padmaja P, Elizabeth D, Padhye AA, Warnock DW.

Med Mycol. 2002 Jun;40(3):307-9.

PMID:
12146761
36.

Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates.

Arthington-Skaggs BA, Lee-Yang W, Ciblak MA, Frade JP, Brandt ME, Hajjeh RA, Harrison LH, Sofair AN, Warnock DW; Candidemia Active Surveillance Group.

Antimicrob Agents Chemother. 2002 Aug;46(8):2477-81.

37.

Epidemiology and Prevention of Invasive Aspergillosis.

Warnock DW, Hajjeh RA, Lasker BA.

Curr Infect Dis Rep. 2001 Dec;3(6):507-516.

PMID:
11722807
38.

Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998.

Brandt ME, Pfaller MA, Hajjeh RA, Hamill RJ, Pappas PG, Reingold AL, Rimland D, Warnock DW; Cryptococcal Disease Active Surveillance Group.

Antimicrob Agents Chemother. 2001 Nov;45(11):3065-9.

39.

Antifungal susceptibility testing: practical aspects and current challenges.

Rex JH, Pfaller MA, Walsh TJ, Chaturvedi V, Espinel-Ingroff A, Ghannoum MA, Gosey LL, Odds FC, Rinaldi MG, Sheehan DJ, Warnock DW.

Clin Microbiol Rev. 2001 Oct;14(4):643-58, table of contents. Review.

40.

Counterpoint: invasive aspergillosis and the environment--rethinking our approach to prevention.

Hajjeh RA, Warnock DW.

Clin Infect Dis. 2001 Nov 1;33(9):1549-52. Epub 2001 Sep 24. Review.

PMID:
11568854
41.

Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B.

McGinnis MR, Nordoff N, Li RK, Pasarell L, Warnock DW.

Med Mycol. 2001 Aug;39(4):369-71.

PMID:
11556767
42.

Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits.

Lasker BA, Elie CM, Lott TJ, Espinel-Ingroff A, Gallagher L, Kuykendall RJ, Kellum ME, Pruitt WR, Warnock DW, Rimland D, McNeil MM, Reiss E.

Med Mycol. 2001 Aug;39(4):341-52.

PMID:
11556764
43.

Antifungal drug susceptibility testing and resistance in Aspergillus.

Warnock DW, Arthington-Skaggs BA, Li RK.

Drug Resist Updat. 1999 Oct;2(5):326-334.

PMID:
11504507
44.

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, Warnock DW.

Clin Infect Dis. 2001 Sep 1;33(5):641-7. Epub 2001 Jul 30. Review.

PMID:
11486286
45.

Gastrointestinal basidiobolomycosis in Arizona: clinical and epidemiological characteristics and review of the literature.

Lyon GM, Smilack JD, Komatsu KK, Pasha TM, Leighton JA, Guarner J, Colby TV, Lindsley MD, Phelan M, Warnock DW, Hajjeh RA.

Clin Infect Dis. 2001 May 15;32(10):1448-55. Epub 2001 Apr 20. Review.

PMID:
11317246
46.

In vitro antifungal susceptibility methods and clinical implications of antifungal resistance.

Espinel-Ingroff A, Warnock DW, Vazquez JA, Arthington-Skaggs BA.

Med Mycol. 2000;38 Suppl 1:293-304. Review.

PMID:
11204157
47.

Infection may not have been caused by Exophiala jeanselmei.

Padhye AA, Warnock DW.

Clin Infect Dis. 2000 Sep;31(3):845-6. No abstract available.

PMID:
11017850
48.
50.

Aspergillus antigen testing in bone marrow transplant recipients.

Williamson EC, Oliver DA, Johnson EM, Foot AB, Marks DI, Warnock DW.

J Clin Pathol. 2000 May;53(5):362-6. Erratum in: J Clin Pathol 2001 May;54(5):416.

Supplemental Content

Loading ...
Support Center